Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Claris Lifesciences Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12336
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company provides generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. It provides products are offered through various delivery systems such as bags, vials, ampoules, cartridges, glass bottles and plastic bottles. It manufactures and markets products in different markets and therapeutic segments including anesthesia and analgesia, nutrition, blood products, anti-infectives, orphan diseases, hormonal disorders, renal and transplant, oncology and critical care. The company serves institutions, government and private hospitals, aid agencies, and nursing homes. It operates through its manufacturing facility located in Ahmedabad, Gujarat. Claris is headquartered in Ahmedabad, Gujarat, India.

Claris Lifesciences Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Claris Lifesciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
OrbiMed Advisors Acquires Minority Stake In Claris Lifesciences For US$4 Million 11
Signet Healthcare Partners Acquires 2.2% Stake In Claris Lifesciences For US$4 Million 12
Partnerships 13
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 13
Claris Lifesciences Enters Into Distribution Agreement With Stravencon 14
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 15
Acquisition 17
Athanas Enterprise and Abellon CleanEnergy to Acquire Remaining 49.87% Stake in Claris Lifesciences 17
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 18
Baxter Acquires Claris Injectables for USD625 Million 19
Claris Lifesciences Ltd – Key Competitors 21
Claris Lifesciences Ltd – Key Employees 22
Claris Lifesciences Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Claris Lifesciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Claris Lifesciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
OrbiMed Advisors Acquires Minority Stake In Claris Lifesciences For US$4 Million 11
Signet Healthcare Partners Acquires 2.2% Stake In Claris Lifesciences For US$4 Million 12
Claris Lifesciences Enters into Distribution Agreement with Stada Arzneimittel 13
Claris Lifesciences Enters Into Distribution Agreement With Stravencon 14
Claris Lifesciences Forms Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 15
Athanas Enterprise and Abellon CleanEnergy to Acquire Remaining 49.87% Stake in Claris Lifesciences 17
Otsuka Pharma Acquires 20% Stake in Otsuka Pharma India from Claris for USD20 Million 18
Baxter Acquires Claris Injectables for USD625 Million 19
Claris Lifesciences Ltd, Key Competitors 21
Claris Lifesciences Ltd, Key Employees 22
Claris Lifesciences Ltd, Subsidiaries 23
Claris Lifesciences Ltd, Joint Venture 24

List of Figures
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Claris Lifesciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Claris Lifesciences Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Claris Lifesciences Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transcatheter Technologies GmbH-医療機器分野:企業M&A・提携分析
    Summary Transcatheter Technologies GmbH (Transcatheter) is a medical equipment company that develops aortic valve implantation system. The company develops technologies for self-expanding valve prostheses and endovascular stents through inner catheters. It develops aortic valve implantation system f …
  • Probiodrug AG (PBD):製薬・医療:M&Aディール及び事業提携情報
    Summary Probiodrug AG (Probiodrug) is a clinical stage biopharmaceutical company that conducts research and development of new medicines for the treatment of Alzheimer’s disease. The company provides three pipeline drug candidates such as PQ912, PBD-C06 and PQ1565. Its PQ912 drug candidate is a smal …
  • Haworth Inc:企業の戦略的SWOT分析
    Haworth Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • EP Energy Corp (EPE):石油・ガス:M&Aディール及び事業提携情報
    Summary EP Energy Corp (EP Energy) is an oil and gas exploration and production company that offers acquisition and development of unconventional onshore oil and natural gas properties in the US. The company operates Altamont program, Eagle Ford program and Wolfcamp program. Its Eagle Ford program i …
  • Seven Energy International Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Seven Energy International Ltd (Seven Energy) is an oil and gas company. The company explores, develops and distributes oil and gas interests. It provides crude oil and gas. Seven Energy offers upstream oil and gas, midstream gas processing and pipeline infrastructure services. The company’s …
  • Nippon Shikizai Inc.:企業の戦略・SWOT・財務情報
    Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report Summary Nippon Shikizai Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Reyes Holdings LLC:企業の戦略的SWOT分析
    Reyes Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Wesfarmers Limited:企業の戦略・SWOT・財務分析
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Qurate Retail, Inc.:企業の戦略・SWOT・財務情報
    Qurate Retail, Inc. - Strategy, SWOT and Corporate Finance Report Summary Qurate Retail, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • T-System Inc:医療機器:M&Aディール及び事業提携情報
    Summary T-System Inc (T-System) is a provider of healthcare IT solutions with focus on emergency department documentation. T-System develops solutions for the episode-based care market, which includes emergency departments (EDs) in hospitals, freestanding emergency centers and urgent care centers. B …
  • Freehold Royalties Ltd (FRU):石油・ガス:M&Aディール及び事業提携情報
    Summary Freehold Royalties Ltd (Freehold Royalties), formerly Freehold Royalty Trust is an oil and gas company that offers oil and gas operation and financial performance. The company's oil and gas assets generate income from natural gas, crude oil, natural gas liquids and potash deposits. It provid …
  • Quantum Corp (QTM):企業の財務・戦略的SWOT分析
    Summary Quantum Corp (Quantum) is a technology company that offers intelligent solutions for capturing, sharing and preserving digital assets over the data lifecycle. The company provides products such as stornext scale-out storage, Q-cloud archive, quantum archives, scalar , LTO Tape Drives, DXi de …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Oaktree Capital Group Llc
    Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group Llc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bina Puri Holdings Bhd:企業の戦略・SWOT・財務情報
    Bina Puri Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Bina Puri Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Lakeland Financial Corporation:企業の戦略・SWOT・財務情報
    Lakeland Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Lakeland Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Taisho Pharmaceutical Holdings Co Ltd:企業の戦略・SWOT・財務情報
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • W.W. Grainger, Inc.:企業の戦略・SWOT・財務情報
    W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report Summary W.W. Grainger, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆